Search results
La mastectomía profiláctica contralateral (MPC) ha sido evaluada como estrategia para la reducción del riesgo de cáncer de mama contralateral (CMC) en pacientes con un cáncer de mama esporádico (es decir, sin mutaciones en los principales genes asociados al cáncer de mama hereditario, y sin una fuerte historia familiar) 1.
20 lip 2005 · Contralateral breast cancer (CBC) is the most common second primary cancer in patients diagnosed with breast cancer. 1 Patients with a history of breast cancer have an increased risk of developing a second primary breast cancer (PBC), with an annual risk of 0.5% to 1% or a cumulative lifetime risk of 2% to 15%. 2 Because breast cancer is the ...
9 lip 2024 · The materials can be downloaded for free in PDF format, bookmarked or shared with loved ones. You can also find our educational resources in Spanish within Komen en Español. Learn about Interpreter (Translator) Services.
A cancer in the contralateral breast in a woman with a previous or synchronous breast cancer is typically considered to be an independent primary tumor. Emerging evidence suggests that in a small subset of these cases the second tumor represents a metastasis.
2 cze 2022 · This study seeks to determine the risk of SPCs, including contralateral breast cancer (CBCa), in women with early-stage invasive lobular carcinoma (ILC). Methods: The study population consisted of women with BCa diagnosis between 2000-2018 within the NCI Surveillance, Epidemiology, and End Results (SEER v 3.2.9) registry and between 2000-2021 ...
26 maj 2021 · Women with unilateral breast cancer experience an annual risk of contralateral breast cancer ~0.4% per year, which persists over the 25-year follow-up period.
3 lis 2020 · We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ (DCIS) compared with invasive breast cancer (BC).
